shr-2173
Biologicsexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 28, 2024 (NCT06995001)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07289763 | Phase 2 | Jan 31, 2026 | Hengrui Therapeutics, Inc. |
| NCT07299422 | Phase 2 | Dec 31, 2025 | Hengrui Therapeutics, Inc. |
| NCT07229742 | Phase 2 | Nov 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT07206758 | Phase 1 | Nov 12, 2025 | Hengrui Therapeutics, Inc. |
| NCT06955598 | Phase 1 | Nov 24, 2024 | Hengrui Therapeutics, Inc. |
| NCT06995001 | Phase 1 | Apr 28, 2024 | Hengrui Therapeutics, Inc. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 6 | 6 | 2 | 2024 |
1 organizations
Page 1 / 1